Review and update: Current treatment trends for patients with retinitis pigmentosa

Optometry

Volumn 80, Issue 7, 2009, Pages 384-401

  Shintani, Kelly ^a   Shechtman, Diana L ^b   Gurwood, Andrew S ^c  

^a Orinda Optometry Group   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c PENNSYLVANIA COLLEGE OF OPTOMETRY   (United States)

Author keywords

Gene therapy; Neuro prosthetic devices; Photoreceptor degeneration; Retinal transplantation; Retinitis pigmentosa

Indexed keywords

VITAMIN;

ANIMAL; ARTICLE; CELL TRANSPLANTATION; COUNSELING; DRUG THERAPY; ELECTROPHYSIOLOGY; GENE THERAPY; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; RETINITIS PIGMENTOSA; THERAPY; VISUAL DISORDER;

ANIMALS; CELL TRANSPLANTATION; COUNSELING; DRUG THERAPY; ELECTROPHYSIOLOGY; GENE THERAPY; HUMANS; RETINITIS PIGMENTOSA; THERAPEUTICS; VISION DISORDERS; VITAMINS;

EID: 67649510373     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2008.01.026     Document Type: Article

References (204)

1. Marshall J., and Heckenlively J.R. Retinitis pigmentosa (1988), J.B. Lippincott Co, Philadelphia 37-42
2. nd ed (1994), Mosby-Year Book, Inc, St. Louis 334-340
3. nd ed Vol 3 (1994), WB Saunders, Philadelphia 1214
4. Ammann F., Klein D., and Franceschetti A. Genetic and epidemiological investigation of pigmentary degeneration of the retina and allied disorders in Switzerland. J Neurol Sci 2 (1965) 183-196
5. Haim M. Epidemiology of retinitis pigmentosa in Denmark. Acta Ophthalmol Scand Suppl 233 (2002) 1-34
6. Boughman J.A., Conneally P.M., and Nance W.E. Population genetic studies of RP. Am J Hum Genet 32 (1980) 223-235
7. Haim M. Epidemiology of retinitis pigmentosa in Denmark. Acta Ophthalmol Scan Suppl 233 (2002) 1-34
8. Berson E.L. Retinitis pigmentosa: The Friedenwald Lecture. Invest Ophthalmol Vis Sci 34 (1993) 1659-1676
9. Donders F.C. Beitrage zur pathologischen Anatomie des Auges: Pigmentbildung in der Netzhaut. Albrecht von Graefes Arch Ophthalmol 3 (1857) 139-150
10. Wong F. How shall research in the treatment of retinitis pigmentosa proceed?. Arch Ophthalmol 111 (1993) 754-756
11. Marmor M.F., Aguirre G., Arden G., et al. Retinitis pigmentosa. Ophthalmol 90 (1983) 126-131
12. Carr R.E., and Noble K.G. Retinitis pigmentosa and allied diseases. In: Guyer D.R., Yannuzzi L.A., Chang S., et al. (Eds). Retina-vitreous-macula (1988), W.B. Saunders, Co, Philadelphia 891
13. nd ed. (1994), Mosby-Year Book, Inc, St. Louis 354
14. Weinstein R. Phytanic acid storage disease (Refsum's disease): clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management. J Clin Apheresis 14 (1999) 181-184
15. Wong F. Investigating retinitis pigmentosa: a laboratory scientist's perspective. Progress in Retinal Eye Research 16 (1997) 353-373
16. Baumgartner W.A. Etiology, pathogenesis, and experimental treatment of RP. Medical Hypotheses 54 (2000) 814-824
17. John S.K., Smith J.E., Aguirre G.D., et al. Loss of cone molecular markers in rhodopsin-mutant human retinas with retinitis pigmentosa. Molecular Vision 6 (2000) 204-215
18. Farrar J.G., Kenna P.F., and Humphries P. On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. EMBO J 2 (2002) 857-864
19. McKie A.B., McHale J.C., Keen T.J., et al. Mutations in the pre-mRNA splicing factor gene PRPc8 in autosomal dominant retinitis pigmentosa (RP13). Hum Mol Genet 10 (2001) 1555-1562
20. Abu-Safieh E.V.L., Carrey A., Papaioannou M., et al. A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa or chromosome 19q13.4 (RP11). Mol Cell 8 2 (2001) 375-381
21. Strettoi E., and Pignatelli V. Modifications of retinal neurons in a mouse model of retinitis pigmentosa. Proc Nat Acad Sci U S A 97 (2000) 11020-11025
22. Humphries M.M., Rancourt D., Farrar G.J., et al. Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nat Genet 15 (1997) 115-117
23. Daiger SP, Sullivan LS, Bowne S. et al. Retnet. Available at: www.sph.uth.tmc.edu/Retnet. Last accessed January 25, 2006.
24. Daiger S.P., Sullivan L.S., and Rodriguez J.A. Behav Brain Sci 18 (1995) 452-467
25. Hamel C. Retinitis pigmentosa. Orphanet Encyclopedia (July 2003). http://www.orpha.net/data/patho/GB/uk-RetinitisPigmentosa.pdf Last accessed April 11, 2009
26. Heckenlively J.R., Boughman J.A., and Friedman L.H. Pedigree analysis. In: Heckenlively J.R. (Ed). Retinitis pigmentosa (1988), Lippincott, Philadelphia, PA 6-24
27. RETNET. Available at: http://www.sph.uth.tmc.edu/Retnet/. Last accessed May 14, 2007.
28. Shastry B.S. RP and related disorders. Am J Med Genet 52 (1994) 267-274
29. Weston M.D., Kelley P.M., Overbeck L.D., et al. Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients. Am J Hum Genet 59 (1996) 1074-1083
30. Pagon RA, Daiger SP. Retinitis pigmentosa overview 2005. Available at: http://www.geneclinics.org/profiles/rp-overview/details.html. Last accessed January 25, 2006.
31. Wang D.Y., Chan P.O.S., Baun T.M., et al. Gene mutation in RP and their clinical implications. Clinica Chimica Acata 351 (2005) 5-16
32. Behn D., and Potter M.J. Sildenafil-medicated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase. Invest Ophthalmol Vis Sci 42 (2001) 523-527
33. Marmor M.F., and Kessler R. Sildenafil (Viagra) and ophthalmology. Surv Ophthalmol 44 (1999) 153-162
34. Reig C., Trujillo M.J., Martinez-Gimeno M., et al. Homozygous and heterozygous Gly-188-Arg mutation of the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa. Ophthalm Genet 21 (2000) 79-87
35. Holopigian K., Greenstein V., Seiple W., et al. Rates of changes differ among measures of visual function in patients with RP. Ophthalmol 103 (1996) 398-405
36. Berson E., Sandberg M.A., Rosner B., et al. Natural course of RP over a 3-yr interval. Am J Ophthalmol 99 (1985) 240-251
37. Brown T. Retinitis pigmentosa: October 2005 Available at: http://www.gopbc.org/articles/RP1.pdf. Last accessed May 14, 2007.
38. Phelan JK, Bok D. A brief review of RP and the identified RP genes. June 2000 Available at: http://www.molvis.org/molvis/v6/a16. Last accessed April 30, 2008.
39. Organisciak D.T., and Winkler B.S. Retinal light damage: practical and theoretical considerations. Progress in Retinal and Eye Research 13 (1994) 1-29
40. Fletcher E.L. Alterations in neurochemistry during retinal degeneration. Microscopy Research and Technique 50 (2000) 89-102
41. Miceli M.V., Liles M.R., and Newsome D.A. Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis. Exp Cell Res 214 (1994) 242-249
42. Penn J.S., Shihong L., and Naash M.I. ambient hypoxia reverses retinal vascular attenuation in a transgenic mouse model of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 41 (2000) 4007-4013
43. Pierce E., Quinn T., Meehan T., et al. Mutations in a gene encoding a new oxygen-regulated photoreceptor protein cause autosomal dominant retinitis pigmentosa. Nat Genet 22 (1999) 248-254
44. Turano K.A., Geruschat D.R., Stahl J.W., et al. Perceived visual ability for independent mobility in persons with RP. Invest Ophthalmol Vis Sci 40 (1999) 865-877
45. Granse L., Ponjavic V., and Andeasson S. Full field ERG, mfERG, mfVEP in patients with RP and residual central visual field. Acta Ophthalmol Scand 82 (2004) 701-706
46. Deutman A.F. Rod-cone dystrophy: primary, hereditary, pigmentary retinopathy, retinitis pigmentosa. In: Krill A.E., and Archer D.B. (Eds). Krill's hereditary retinal and choroidal diseases Vol 2 (1977), Harper & Row, Publishers, Inc.,, Hagerstown, MD 479-576
47. Ferrucci S., Anderson S.F., Townsend J.C., et al. RP inverse. Optom Vis Sci 75 (1998) 560-570
48. Michaelides M., Hardcastle A.J., Hunt D.M., et al. Progressive cone and cone-rod dystrophies: phenotypes and underlying molecular genetic basis. Surv Ophthalmol 51 (2006) 232-258
49. Musarella M.A. Patient with Bardet-Biedl syndrome presenting with nystagmus at fifteen months of age. Journal of AAPOS 5 (2001) 262-264
50. Herse P. RP: visual function and multidisciplinary management. Clin Exp Optom 88 (2005) 335-350
51. Alexander K.R., and Fishman G.A. Prolonged rod dark adaptation in retinitis pigmentosa. Br J Ophthalmol 68 (1984) 561-569
52. Sumi I., Matsumoto S., Okajima O., et al. The relationship between visual disability and visual scores in patients with retinitis pigmentosa. Jpn J Ophthalmol 44 (2000) 82-87
53. Marmor M.F. Visual loss in retinitis pigmentosa. Jpn J Ophthalmol 89 (1980) 692-698
54. Fishman G.A. Retinitis Pigmentosa: Visual loss. Arch Ophthalmol 96 (1978) 1185-1188
55. Social Security Administration Publication #64-039. Special Senses 2.03 Blue Book Jan. 2005. Available at: http://www.ssa.gov/disability/professionals/bluebook/2.00-SpecialSensesandSpeech-Adult.htm. Last accessed May 14, 2007.
56. Wang D.Y., Chan P.O.S., Baun T.M., et al. Gene mutation in RP and their clinical implications. Clinica Chimica Acata 351 (2005) 5-16
57. Sandberg M.A., Jacobson S.G., and Berson E.L. Foveal cone ERG in RP and juvenile macular degeneration. Am J Ophthalmol 88 (1979) 702-707
58. Sandberg M.A., Brockhurst R.J., Gaudio A.L., et al. The association between VA and central retinal thickness in RP. Invest Ophthalmol Vis Sci 46 (2005) 3349-3354
59. Young R.S., and Fishman G.A. Color matches of patients with RP. Invest Ophthalmol Vis Sci 19 (1980) 967-972
60. Spadea L., Magni R., Rinaldi G., et al. Unilateral retinitis pigmentosa: Clinical and electrophysiological report of four cases. Ophthalmologica 21 (1998) 350-354
61. Bjork A., and Karpe G. The ERG of RP. Acta Ophthalmol Scand 29 (1951) 361
62. Falls H.F., and Cotterman C.W. Choroidoretinal degeneration: A sex-linked form in which heterozygous women exhibit a tapetal-like retinal reflex. Arch Ophthalmol 40 (1948) 685-703
63. Biro I. Symmetrical development of pigmentation as a specific feature of the fundus pattern in retinitis pigmentosa. Am J Ophthalmol 55 (1963) 1176-1179
64. Van Woerkom C., and Ferrucci S. Sector retinitis pigmentosa. Optometry 76 (2005) 309-317
65. nd ed. (1994), Appleton & Lange, Norwalk, CT 434-40
66. Geltzer A.I., and Berson E.L. Fluorescein angiography of hereditary retinal degenerations. Arch Ophthalmol 81 (1969) 776-782
67. Rajacich G.M., Parelhoff E.S., and Heckenlively J.R. The cup-disc ratio in retinitis pigmentosa subgroups (abstract). Invest Ophthalmol Vis Sci 22 ARVO supp (1982) 55
68. Novack R.L., and Foos R.Y. Drusen of the optic disc in retinitis pigmentosa. Am J Ophthalmol 103 (1987) 44-47
69. Puck A., Tso M., and Fishman G.A. Drusen of the optic nerve associated with retinitis pigmentosa. Arch Ophthalmol 103 (1985) 231-234
70. Spencer W.H. Drusen of the optic disc and aberrant axoplasmic transport (the XXXIV Edward Jackson Memorial Lecture). Am J Ophthalmol 85 (1978) 1-12
71. Takahashi M., Jalkh A., Hoskins J., et al. Biomicroscopic evaluation and photography of liquefied vitreous in some vitreoretinal disorders. Arch Ophthalmol 99 (1981) 1555-1559
72. Ftkenhour G.A., Chromokos E., Weinstein J., et al. CME in RP. Trans Am Acad Ophthalmol Otolaryngol 83 (1977) 515-521
73. Fishman G.A., Maggiero J.M., and Fishman M. Foveal lesions seen in RP. Arch Ophthalmol 96 (1977) 1993-1996
74. Hansen R.I., Friedman A.H., Gartner S., et al. The association of retinitis pigmentosa with preretinal macular gliosis. Br J Ophthalmol 61 (1977) 597-600
75. Heckenlively J. The frequency of posterior subcapsular cataract in the hereditary retinal degenerations. Am J Ophthalmol (1982) 733-738
76. Berson E.L., Rosner B., and Simonoff E. Risk factors for genetic typing and detection in retinitis pigmentosa. Am J Ophthalmol 89 (1980) 763-775
77. Franceschetti A., François J., and Babel J. Tapetoretinal degeneration and keratoconus. In: Francschett A., François J., and Babel J. (Eds). Chorioretinal heredodegeneration (1974), Charles C. Thomas Publisher, Springfield, IL 851-859
78. Sieving P.A., and Fishman G.A. Refractive errors of retinitis pigmentosa patients. Br J Ophthalmol 62 (1978) 163-167
79. Wagner R.S., Caputo A.R., Nelson L.B., et al. High hyperopia in Leber's congenital amaurosis. Arch Ophthalmol 103 (1985) 1507-1509
80. Marmor MF, Zrenner E. Standard for clinical ERG. International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol 1998-9;97:143-56.
81. Arden G.B., and Fojas M.R. Electrophysiological abnormalities in pigmentary degenerations of the retina. Arch Ophthalmol 68 (1962) 369-389
82. Jacobi P.C., Miliczek K., and Zrenner E. Experience with the international standards for clinical practice, inter-individual and intra-individual variations and possible extensions. Doc Ophthalmol 85 (1993) 95-114
83. Carr R.E., and Noble K.G. Retinitis pigmentosa and allied diseases. In: Guyer D.R., Yannuzzi L.A., et al. (Eds). Retina-Vitreous-Macula (1999), W.B. Saunders, Co.,, Philadelphia 908-917
84. Berson E.L., Rosner B., Sandberg M.A., et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 111 (1993) 761-772
85. Massof R.W., Johnson M.A., Sunness J.S., et al. Flicker electroretinogram in retinitis pigmentosa. Doc Ophthalmol 62 (1986) 231-245
86. Scholl H.P., and Kremers J. Large phase differences between L-cone and M-cone-driven electroretinograms in retinitis pigmentosa. Invest Ophthalmol Vis Sci 41 (2000) 3225-3233
87. Maturi R.K., and Bleau L. Multifocal ERG in practice. Rev Ophthalmol 11 (2004) 1-8
88. Robson A.G., El-Amir A., Bailey C., et al. PERG correlates of abnormal fundus auto fluorescence in patients with RP and normal visual acuity. Invest Ophthalmol Vis Sci 44 (2003) 3544-3550
89. Poloschek C.M., and Sutter E.E. The fine structure of mfERG topographies. J Vision 2 (2002) 577-587
90. Chan H.L., and Brown B. Investigation of RP using the mfERG. Ophthal Physiol Opt 18 (1998) 335-350
91. Swanson W.H., Felius J., and Birch D.G. Effect of stimulus size on static visual fields in patients with retinitis pigmentosa. Ophthalmology 107 (2000) 1950-1954
92. Birch D.G., Herman W.K., deFaller J.M., et al. The relationship between rod perimetric thresholds and full-field rod ERGs in retinitis pigmentosa. Invest Ophthalmol Vis Sci 28 (1987) 954-965
93. Jacobson S.G., Voight W.J., Parel J.M., et al. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology 93 (1986) 1604-1611
94. Safran A.B., and Mermoud A. Automated perimetry in retinitis pigmentosa using the Octopus program N1. Neuro-ophthalmology 13 (1993) 199-206
95. Pagon RA, Daiger S. Retinitis pigmentosa overview. Available at: www.geneclinics.org/profiles/rp-overview/details.html. Last accessed September 2005.
96. Massof R.W., Benzschawel T., Emmel T., et al. The spread of retinal degeneration in retinitis pigmentosa (abstract). Invest Ophthalmol Vis Sci 25 ARVO Suppl 3 (1984) 196
97. Massof R.W., and Finkelstein D. A two-stage hypothesis for the natural course of retinitis pigmentosa. Adv Biosci 62 (1987) 29-58
98. Ross D.F., Fishman G.A., Gilbert L.D., et al. Variability of visual fields measurements in normal subjects and patients with retinitis pigmentosa. Arch Ophthalmol 102 (1984) 1004-1010
99. Heijl A., Lindgren G., and Olsson J. Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol 105 (1987) 1544-1549
100. Parks S., Keating D., Evans A.L., et al. Comparison of repeatability of the mfERG and Humphrey perimeter. Doc Ophthalmol Adv Ophthalmol 92 (1997) 281-289
101. Grover S., Fishman G.A., Anderson R.J., et al. Rate of visual field loss in retinitis pigmentosa. Ophthalmology 104 (1997) 460-465
102. Grover S., Fishman G.A., and Brown J. Patterns of visual field progression in patients with retinitis pigmentosa. Ophthalmology 105 (1998) 1069-1075
103. Iannaccomne A., Rispoli E., Vingolo E.M., et al. Correlation between Goldmann perimetry and maximal ERG response in RP.Doc. Ophthalmologica 90 (2005) 129-142
104. Hirakawa H., Iijima H., Gohdo T., et al. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa. Am J Ophthalmol 128 (1999) 185-191
105. Apushkin M., Fishman G., and Janowicz B. Monitoring CME by OCT in patients with RP. Ophthalmology 111 (2004) 1899-1904
106. Jurklies B., Zrenner E., and Wessing A. RP: Clinical, genetic and pathophysiologic aspects. Klin Monatsbl Augenheilkd 210 (1997) 1-18
107. Greenberg J., Bartmann L., Ramesar R., et al. Retinitis pigmentosa in southern Africa. Clin Genet 44 (1993) 232-235
108. Foundation for fighting blindness. Available at: http://www.blindness.org. Last accessed January 2008.
109. Mangione C.M., Phillips R.S., Seddon J.M., et al. Development of the 'Activities of Daily Vision Scale'. A measure of visual functional status. Med Care 30 (1992) 1111-1126
110. Rand Health. http://rand.org/health/surveys_tools/vfq. Last accessed May 1, 2008.
111. Fonda G. Low vision correction in RP and associated diseases. Int J Rehabil Res 3 (1980) 39-43
112. Morrissette D.L., Marmor M.F., and Goodrich G.L. An evaluation of night vision mobility aids. Ophthalmology 90 (1983) 1226-1230
113. Vargas-Martin F., and Peli E. Augmented-view for restricted visual field: multiple device implementations. Opt and Vis Sci 79 11 (2002) 715-723
114. Croughs P. Filtering lenses in retinopathy. Bull Soc Belge Ophthalmol 264 (1997) 119-124
115. Wetzel C., Auffarth G.U., Krastel H., et al. Improving contrast sensitivity by cut-off filters in high adaptation luminance levels in RP. Ophthalmology 93 (1996) 456-462
116. Zigman S. Light filters to improve vision. Optom Vis Sci 68 (1992) 325-328
117. Rosenblum Y.Z., Zak P.P., Ostrovsky M.A., et al. Spectral filters in low vision correction. Ophthalmic Physiol Opt 20 (2000) 335-341
118. Everson R.W., and Schmidt I. Protective spectacles for RP patients. J Am Optom Assoc 47 (1976) 738-744
119. Young R.W. The family of sunlight related eye disease. Optom Vis Sci 71 (1994) 125-144
120. Berson E.L. Nutrition and Retinal Degenerations. Int Ophthalmol Clin 40 4 (2000) 93-111
121. Zhao D.Y., Wintch S.W., Ermakov I.V., et al. Resonance Raman measurement of macular carotenoids in retinal, choroidal, and macular dystrophies. Arch Ophthalmol 121 (2003) 967-972
122. Aleman T.S., Duncan J.L., Bieber M.L., et al. Macular pigment and lutein supplementation in RP and Usher's syndrome. Invest Ophthalmol Vis Sci 42 (2001) 1873-1881
123. Pawlyk B.S., Li T., Scimeca M.S., et al. Absence of photoreceptor rescue with D-cis-diltiazem in the rd mouse. Invest Ophthalmol Vis Sci 43 (2002) 1912-1915
124. Frasson M., Sahel J.A., Fabre M., et al. RP: Rod photoreceptor rescue by a calcium channel blocker in the rd mouse. Nature Medicine 5 (1999) 1183-1187
125. Organisciak D.T., Bicknell I.R., and Darrow R.M. The effects of L-and D-ascorbic acid administration on retinal tissue levels and light damage in rats. Curr Eye Res 11 (1992) 231-241
126. Berson E.L., Rosner B., Sandberg M.A., et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 111 6 (1993) 761-772
127. Sibulesky L., Hayes K.C., Pronczuk A., et al. Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa. Am J Clin Nutr 69 4 (1999) 656-663
128. USDRA. Available at: http://fnic.nal.usda.gov/nal_display/index.php?info_center=4&tax_level=1&tax_subject=242. Last accessed January 2008.
129. Bazan N.G., Scott B.L., Reddy T.S., et al. Decreased content of DHA and arachidonate in plasma phospholipids in Usher's syndrome. Biochem Biophys Res Comm 141 (1986) 600-604
130. Gong J., Rosner B., and Rees D.G. Plasma DHA levels in various genetic forms of RP. Invest Ophthalmol Vis Sci 33 (1992) 2596-2602
131. Berson E., Rosner B., Sandberg M., et al. Further evaluation of DHA in patients with RP receiving vitamin A treatment. Arch Ophthalmol 122 (2004) 1306-1314
132. Berson L., Rosner B., Sandberg M., et al. Vitamin A supplementation for retinitis pigmentosa. Arch Ophthalmol 111 (1993) 1456-1459
133. Patek A.J., and Haig C. The occurrence of abnormal dark adaptation and its relation to vitamin A metabolism in patients with cirrhosis of the liver. J Clin Invest 18 (1939) 609-616
134. nd ed. (1992), Butterworth-Heinemann, Stoneham 213
135. Vingolo E.M., Pelaia P., Forte R., et al. Does hyperbaric oxygen delivery rescue retinal photoreceptors in RP?. Doc Ophthalmol 114 (1996) 560-563
136. Berson E.L. Light deprivation for early retinitis pigmentosa. A hypothesis. Arch Ophthalmol 85 (1971) 521-529
137. Cox N., Hay E., and Bird A.C. Treatment of macular edema with acetazolamide. Arch Ophthalmol 106 (1988) 1190-1195
138. Fishman G.A., Gilbert L.D., Anderson R.J., et al. Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 101 (1994) 687-693
139. Chen J., Fitzke F., and Bird A.C. Long term effect of acetazolamide in a patient with retinitis pigmentosa. Invest Ophthalmol Vis Sci 31 (1990) 1914-1918
140. Moldow B., Sander B., and Larsen M. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. Graefes Arch Clin Exp Ophthalmol 236 (1998) 881-889
141. Jackson H., Garway-Heath D., Rose P., et al. Outcome of cataract surgery in patients with RP. Br J Ophthalmol 85 (2001) 936-938
142. Moosajee M. Genes and the eye. J R Soc 98 (2005) 206-207
143. Acland G.M., Aguirre G.D., Ray J., et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 28 (2001) 92-95
144. Sarra G.M., Stephens C., deAlwis M., et al. Gene replacement therapy in the retinal degeneration slow mouse. Hum Mol Genet 10 (2001) 2353-2361
145. Cayouette M., and Gravel C. Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. Hum Gene Ther 8 (1997) 423-430
146. Cayouette M., Behn D., and Sendtner M. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J Neurosci 18 (1998) 9282-9293
147. Nickels R.W., and Zack D.J. Apoptosis in ocular disease: a molecular overview. Ophthalmic Genetic 17 (1996) 145-165
148. Anderson W.F. Human gene therapy. Science 256 (1992) 808-813
149. Drenser K.A., et al. Ribozyme-targeted destruction of RNA associated with autosomal dominant retinitis pigmentosa. Inv Ophthal Vis Sci 9 50 (1998) 681-689
150. Shaberman BA. Nanoparticles show promise for delivering vision-restoring genes to the retina, June 4, 2007. Available at: www.blindness.org. Last accessed April 11, 2009.
151. Santos A., Humayun M.S., de Juan E., et al. Preservation of the inner retina in RP. Arch Ophthalmol 115 (1997) 511-515
152. del Cerro M., Ison J.R., Bowen G.P., et al. Intraretinal grafting restores visual function in light-blinded rats. Neuroreport 2 (1991) 529-532
153. Smith L.E.H. Bone marrow-derived stem cells preserve cone vision in retinitis pigmentosa. J Clin Invest 114 (2004) 755-777
154. Aramant R.B., and Seiler M.J. Progress in retinal sheet transplantation. Progress in Retinal and Eye Research 23 (2004) 475-494
155. Lund R.D., Ono S.J., Keegan D.J., et al. Retinal transplantation: progress and problems in clinical application. J Leukocyte Biol 74 (2003) 151-160
156. Canola K., Angénieux B., and Tekaya M. Retinal stem cells transplanted into models of late stages of retinitis pigmentosa preferentially adopt a glial or a retinal ganglion cell fate. Invest Ophthalmol Vis Sci 48 (2007) 446-454
157. Sadda SVR, Srinivas R. Retinal cell transplantation as a means of visual restoration. First DOE Biomedical Engineering Contractors Meeting, May 16-18, 2000, Albuquerque, NM.
158. MacLaren R.E., Perason R.A., MacNeil A., et al. Retinal repair by transplantation of photoreceptor precursors. Nature 444 (2006) 203-207
159. Kurimoto Y., Shibuki H., Kaneko Y., et al. Transplantation of adult rat hippocampus-derived neural stem cells into retina injured by transient ischemia. Neurosci Lett 306 (2001) 57-60
160. Smith L.E.H. Bone marrow-derived stem cells preserve cone vision in retinitis pigmentosa. J Clin Invest 114 (2004) 755-757
161. Das A.M., Zhao X., and Ahmad I. Stem cell therapy for retinal degeneration: retinal neurons from heterologous sources. Semin Ophthalmol 20 (2005) 3-10
162. Das T., del Cerro M., Jalali S., et al. The transplantation of human fetal neuroretinal cells in advance RP patients: results of a long-term safety study. Exp Neurol 157 (1999) 58-68
163. Humayun M.S., de Juan E., del Cerro M., et al. Human neural retinal transplantation. Invest Ophthalmol Vis Sci 41 (2000) 3100-3106
164. Radtke N.D., Aramant R.B., Seiler M.J., et al. Vision change after sheet transplant of fetal retina with retinal pigment epithelium to a patient with retinitis pigmentosa. Arch Ophthalmol 122 8 (2004) 1159-1165
165. Gouras P., Du J., Gelanze M., et al. Survival and synapse formation of transplanted rat rods. Journal of Neural Transplantation & Plasticity 2 (1991) 91-100
166. Radtke, and Norman D. Transplantation of intact sheets of fetal neural retina with its retinal pigment epithelium in retinitis pigmentosa patients. Am J Ophthalmol 133 4 (2002) 544-550
167. Gieser J.P. Ethics and human fetal retinal pigment epithelium transplantation. Arch Ophthalmol 119 (2001) 899-900
168. Goureau O., and Sahel J.A. Retinal stem cells: mechanism of differentiation and therapeutic application. Pathologie Biologie 54 (2006) 64-71
169. Foundation for Blindness. Human neural stem cells show potential for vision rescue. May 2007. Available at: http://www.blindness.org/index.php?option=com_content&view=article&id=1172:human-neural-stem-cells-show-potential-for-vision-rescue&catid=65:retinitis-pigmentosa&Itemid=121. Last accessed April 11, 2009.
170. del Cerro M, DiLoreto DA, del Cerro C. Human neural retinal transplants INTO retinitis pigmentosa: facts and controversy. DJO 1998; vol 4. Available at: http://www.djo.harvard.edu/site.php?url=/physicians/oa/379. Last accessed April 12, 2009.
171. Human neural retinal transplants INTO retinitis pigmentosa: facts and controversy. DJO 1998; vol 4(5). Available at: http://www.djo.harvard.edu/site.php?url=/physicians/oa/379&drop=1. Last accessed April 11, 2009.
172. Faktorovich E.G., Steinberg R.H., Yasumura D., et al. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 347 (1990) 83-86
173. LaVail M.M., Yasumura D., Matthes M.T., et al. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci 39 (1998) 592-602
174. Sieving PA, DiLoreto DD, del Cerro C, et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants, 2006. Available at: www.pnas.org/cgi/doi/10.1073/pnas.0600236103. Last accessed May 14, 2007.
175. Krastel H., Anton-Lamprecht I., Alexandridis E., et al. Symptomatic tapetoretinal degeneration in pigment disorders of the skin: Approaches to understanding the pathomechanism and therapy. Fortschritte der Ophthalmologie 82 (1985) 562-570
176. Tatton W.G., and Chalmers-Redman R.M.E. Modulation of gene expression rather than monoamine oxidase inhibition: Deprenyl-related compounds in controlling neurodegeneration. Neurology 47 (1996) S171-S183
177. Dixit S.N., Behari M., and Ahuja G.K. Effect of selegiline on cognitive functions in Parkinson's disease. J Assoc Physicians India 47 8 (1999) 784-786
178. Hambercht F.T. The history of neural stimulation and its relevance to future neural prostheses. In: Agnew W.F., and McCreery D.B. (Eds). Neural prostheses: fundamental studies (1990), Prentice Hall, NJ 90
179. Wyatt J., and Rizzo J. Ocular implants for the blind. Spectrum, IEEE 33 (1996) 47-53
180. Bak M., Grivin J.P., Hambrecht F.T., et al. Visual sensation produced by intracortical microstimulation of the human occipital cortex. Med Biol Eng Comp 25 (1990) 257-259
181. Dobelle W.H. Artificial vision for the blind by connecting a television camera to the visual cortex. ASAIO J 46 (2000) 3-9
182. Cheung K.C., Djupsund K., Dan Y., et al. Implantable mutichannel electrodes array based on SOI technology. J Mircoelectromech System 12 (2003) 1091-1092
183. Chow A.Y., Chow V.Y., Packo K.H., et al. The artificial silicon retina microchip for the treatment of vision loss from RP. Arch Ophthalmol 122 (2004) 460-469
184. Potts A.M., and Inoue J. The electrically evoked response of the visual system. Invest Ophthalmol Vis Sci 8 (1969) 605-612
185. Humayun M.S., Weiland J.D., Fujii G.Y., et al. Visual perception in a blind subject with a chronic microelectric retinal prosthetic. Vision Res 43 (2003) 2573-2581
186. Nadig M.N. Development of a silicon retinal implant: cortical evoked potentials following focal stimulation of the rabbit retina with light and electricity. Clin Neurophysiol 110 (1999) 1545-1553
187. Hossain P., Seetho I.W., Browning A.C., et al. Artificial means for restoring vision. BMJ 330 (2005) 30-33
188. Fang X., Sakaguchi H., Fujikado T., et al. Direct stimulation of optic nerve by electrodes implanted in optic disc of rabbit eyes. Graefe's Arch Clin Exp Ophthalmol 243 (2005) 49-56
189. Duret F., Brelen M.E., Lambert V., et al. Object localization, discrimination, and grasping with the optic nerve visual prosthesis. Restor Neurol Neurosci 24 (2006) 31-40
190. Dowling J. Artificial human vision. Exp Rev Med Dev 2 (2005) 73-85
191. Rizzo J., Wyatt J., Loewenstein J., et al. Methods and perceptual for short-term electrical stimulation of human retina with microelectrodes arrays. Invest Ophthalmol Vis Sci 44 (2003) 5355-5361
192. Humayum M.S., Sato Y., Propst R., et al. Can potential from the visual cortex be elicited electronically despite severe retinal degeneration and markedly reduced ERG. German J Ophthalmol 4 (1995) 57-64
193. Jahaveri M., Hahn D.S., Lakhanpal R.R., et al. Retinal prosthesis for the blind. Ann Acad Med Singapore 35 (2006) 137-144
194. Winter J.O., Cogan S.F., and Rizzo III J.F. Retinal prostheses: current challenges and future outlook. Journal of Biomaterials Science-Polymer Edition 18 8 (2007) 1031-1055
195. TM II Retinal Stimulation System Feasibility Protocol. Available at: http://clinicaltrials.gov/ct2/show/record/NCT00407602?term=retinal+prosthesis&rank=1. Last accessed October 23, 2008.
196. Meijer P.B.L. An experimental system for auditory images representations. IEEE Trans Biomed Eng 39 (1992) 112-121
197. Vision technology for the totally blind. Available at: http://www.seeingwithsound.com. Last accessed January 2008.
198. Eckmiller R.E., Neumann D., and Baruth O. Test technology for retina implants in primates (ARVO abstract). Invest Ophthalmol Vis Sci 42 (2001) S942
199. Troyk P., Bak M., Berg J., et al. A model for intracortical visual prosthesis research. Artificial Organs 27 (2003) 1005-1015
200. Universal low vision Inc. Voice note. Available at: http://www.ulva.com/Online-Store/GPS/sendero-gps.htm. Last accessed May 1, 2008.
201. Iezzi R. New advances in artificial vision. Rev Ophthal 9 8 (2002) 64
202. Eyegene. Available at: www.nei.nih.gov/resources/eyegene.asp. Last accessed May 1, 2008.
203. Bainbridge J.W.B., Smith A.J., Barker S.S., et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358 (2008) 2231-2239
204. Maguire A.M., Simonelli F., and Pierce E.A. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358 (2008) 2240-2248